News

Small caps round-up: Avanti, York Pharma, Ocean Power

02 October 2006 11:45:00

Avanti Screenmedia said results for the year demonstrate significant growth with both its divisions achieving key milestones. Pre-tax profit jumped to £3m from £1.9m last year on turnover that rose 54% to £12.9m.

Pharmaceutical products developer York Pharma said it has begun to prepare for the launch of Abasol for the first half of 2007 after receiving a response from the UK's Medicines and Healthcare products Regulatory Agency (MHRA).

Wave power station group Ocean Power Technologies said it has signed a marketing cooperation agreement with Lockheed Martin to identify and jointly pursue sales opportunities.

Gene therapy group Oxford BioMedica and The Foundation Fighting Blindness announced that they have signed a research and collaboration agreement to develop a portfolio of gene therapy products for the treatment of eye diseases.

Vebnet announces that it acquired the entire issued share capital of 4th Contact from Star Technology Services for a maximum consideration of £661,000.

Gold exploration group Pan African Resources said it is pleased the work completed on the Fair Bride prospect within the Manica Project indicates that the metallurgical results at a basic stage without optimisation are 'excellent.'

All data suppied by Digital Look (15 minute delay)




Risk Warning

There is an extra risk of losing money when shares are bought in some smaller companies including 'Penny Shares'. There is a big difference between the buying price and the selling price of these shares. If they have to be sold immediately, you may get back much less than you paid for them or you may have difficulty in selling them. Past performance is not a reliable indicator of future results. The price may change quickly and it may go down as well as up. You could lose every penny put into a particular share.

The information contained above has been compiled from documented sources which are believed to be reliable but, due to their very nature, are subject to a degree of historical inaccuracy and have not been independently verified and cannot be guaranteed. The pages on this website are provided for information only. City Equities Limited will not accept responsibility for loss incurred by any person or body acting, or refraining from acting, as a result of information and/or opinions given anywhere on this website. Issued by City Equities Limited, Aldermary House, 10-15 Queen Street, London, EC4N 1TY. Registered in England. Registered No. 2742847. Registered Address: Amwell House, 19 Amwell Street, Hoddeson, Herts. EN11 8TS. City Equities Limited is Authorised and regulated by the Financial Services Authority. Registration No. 155051.